Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Case Report
Stomatitis Medicamentosa‒a Case Report
Shaik Md. Asif1, Sultan Mohammed Kaleem1, Shefali Waghray2, Naheeda Shaheen3, and Renu Tanwar4
1Maxillo Facial Diagnostic Sciences, College of Dentistry, King Khalid University, Abha. Kingdom of Saudi Arabia.2Pananeya Dental College, Hyderabad, Andhra Pradesh, India.3Mamatha Dental College, Khammam. Andhra Pradesh, India.4SGT Dental College, Gurgaon, New Delhi, India.
Article History
Received 24 November 2011
Accepted � April 2012
Keywords :
stomatitis medicamentosa; IgE reac-
tion; eosinophils
Abstract
Mucosal allergies represent a growing problem and often go undiagnosed by health
professionals. The prevalence of mucosal allergies due to drugs routinely prescribed in
dental practice appears to be increasing. Ingestion of certain drugs by individuals with
idiosyncratic reactions or intolerance may result in allergic manifestations referred to as
stomatitis medicamentosa. The clinical features may vary from a burning sensation to
ulcerative lesions in the oral cavity. These lesions resolve with discontinuation of the
causative agent. However, antihistamines and steroids are the drugs of choice in severe
cases. We describe herein the case of a 45-year-old woman with an allergic reaction to an
Over- the- Counter drug, treated in the Department of Oral Medicine & Radiology at D.A.
Pandu Memorial R.V. Dental College, Bangalore, India. The pathogenesis, clinical features,
diagnosis and treatment are discussed.
Introduction
Drug allergy covers a variety of sensitivity reactions
following exposure to drugs and chemicals, but is unrelated
to any inherent pharmacological activity or toxicity of the
material. Practically every known drug has been recognized
at one time or another as capable of producing an allergic
reaction in a sensitive individual (1)). Certain drugs,
however, have a far great propensity for producing
reactions than others. It is impossible to list even a small
portion of the overwhelming number of drugs that have
been known to produce an allergic reaction (2). Several
categories of allergic reactions have significant oral and
facial involvements. These clinical entities are well defined
and frequently described in the medical and dental
literature(1, 2). The oral mucous membrane may be the
sole site of involvement or may be part of a more
generalized skin reaction to the offending drug. Mucosal
allergies represent a growing problem and often go
undiagnosed by health professionals(3). A mucosal allergic
reaction caused by systemic administration of drugs is
known as stomatitis medicamentosa. We present herein the
case of a 45-year-old woman with acute allergic reaction in
the oral cavity due to a Over- the-Counter drug.
Case report
A 45-year-old woman reported to the Department of Oral
Medicine & Radiology at D.A. Pandu Memorial R.V. Dental
College, Bangalore, India, with a 2-day history of a severe
burning sensation in the oral cavity. Initially the patient
experienced burning sensation within half an hour after
administration of an Over- the- Counter drug (ibuprofen)
she had obtained from the pharmacist for tooth pain. The
burning sensation became suddenly and severely aggra-
vated after administration of a second dose. There was no
history of fever following administration of this drug.. A
history of disturbed sleep and difficulty swallowing due to
the burning sensation was elicited. Her medical, dental and
family histories were non-contributory. The patient was
poorly nourished and of slight build, with no signs of anemia
or icterus. No cutaneous or ocular lesions were apparent.
Intraoral examination revealed multiple (10-12) ulcers at
the vermilion border of the lower lip and angle of the mouth
(Fig. 1). The ulcers were encrusted and showed varying
Int J Oral-Med Sci 11(1):57-61, 2012 57
Correspondence to :
Shaik Md. Asif.
E-mail : [email protected]
sizes of 1-2mm. The dorsal surface of the tongue was
coated with yellowish slough and movements of the tongue
were restricted due to presence of ulcers on the tongue
(Fig. 2). Similar ulcerative lesions measuring 1×2mmwere
seen bilaterally over the entire buccal mucosa. Mouth
opening was restricted due to the presence of ulcers in the
retromolar area. Based on the chief complaint and drug
history, a provisional diagnosis of stomatitis medicamentosa
was made. Differential diagnoses for the lesions included
erythema multiforme (EM). Skin testing was performed on
the inner surface of the patientʼs forearm by intradermal
inoculation of the suspected allergen (ibuprofen). Skin
erythema was apparent at the site of inoculation within 20
min after inoculation. The patient was referred for further
investigations, and peripheral blood smears showed an
increase in relative eosinophil count to 15% (normal, 1-4%)
using Wrightʼs stain to count the eosinophils. The erythro-
cyte sedimentation rate was higher than normal, at 57mm/h
(normal, 0-20mm/h). Periodic acid Schiff staining of
scrapings from lesions was non contributory. An increase in
serum immunoglobulin (Ig) E levels to 1,120IU/ml sug-
gested a type I hypersensitivity reaction. Based on these
investigations, skin test results and the elicited history, we
reached a conclusive diagnosis of stomatitis medicamentosa.
The patient was instructed to discontinue usage of the drug
after diagnosing the condition and was later prescribed
systemic steroids (prednisolone, 60mg/day) for 1 week
along with topical antihistamines (benzydamine hydrochlor-
ide) and germicidal (chlorhexidine) mouthwash. To over-
come complications associated with steroid use, the dosage
was tapered to 30mg/day after the first week. After 3
weeks of therapy, all lesions had completely resolved (Figs.
3, 4) and the patient was referred to an endodontist for
evaluation of the tooth pain.
Discussion
The list of offending medications and their resultant side
effects appears endless. In a short and highly beneficial
article, Matthews listed more than 150 frequently pre-
scribed medications and related them to 46 oral and perioral
side effects(4). The oral mucosa is exposed to a wide range
of ingested medications(5). However, immediate and severe
reactions have been reported in the literature(4, 5).
Pathogenesis
The term“allergy”is used to define a specific immune
reaction to one or more exogenous substances, termed
“allergens”. The immune system is made up of two
functional components: an adaptive component; and an
innate component(6). The innate immune system is situated
in organs such as the skin and mucosa. When an antigen
enters the body, specialized helper T-cells (Th cells)
respond to foreign materials in two ways: Th1 responses;
and Th2 responses. IgE is associated with Th2 responses,
58 Int J Oral-Med Sci 11(1):57-61, 2012
Fig. 1. Multiple ulcers on the vermilion border of the lower lipand angle of the mouth.
Fig. 2. Yellow slough on the dorsal surface of the tongue, withmultiple ulcers on the tongue.
which generally occur immediately after exposure. The
clinical symptoms of IgE reactions are due to inflammatory
Th2 cytokines (7). IgE antibodies also initiate a series of
reactions that result in the release of inflammatory
mediators, such as histamine, C-reactive protein and other
chemicals from specialized cells called mast cells. The role of
mast cells in allergic tissue inflammation is well recognized.
Interleukin (IL)-4 in the presence of stem cell factor (SCF)
regulates the functional status of mast cells and increases
the release of IgE-dependent mediators(8, 9).
Clinical Features
Type I allergic reactions are characterized by Quinckeʼs
edema (angioedema), which can become life threatening for
patients if the upper respiratory tract becomes involved
(10). Type I also cause urticarial reactions on the skin, in the
form of erythematous papules accompanied by pruritus or a
tingling sensation. However, none of these findings were
observed in the present case. The affected mucosa exhibits a
diffuse distribution of lesions varying in appearance from
multiple areas of erythema, to extensive areas of erosion or
ulceration(11). Patients will complain of a burning sensation
with altered taste sensation and difficulty swallowing.
Although the lesions of the oral cavity resembled EM
clinically, this possibility was excluded as a diagnosis due to
absence of target lesions. Biopsy was not performed in this
patient, as the patient reported a severe burning sensation
and because the majority of severe cases of toxic epidermal
necrolysis are caused by drug reactions that usually result
in sloughing of the skin and mucosa in large sheets(12). EM
has been classified according to the degree of mucosal
involvement and the nature and distribution of skin lesions.
As the most common form, EM minor typically affects a
single mucous membrane and may be associated with
target lesions on the extremities(13). EM major is more
severe, typically involving two or more mucous membranes
with more variable skin involvement. This feature is used to
distinguish EM major from Stevens-Johnson syndrome,
which shows extensive skin involvement(13). The micro-
scopic appearance of EM is not diagnostic. Although
considerable variation occurs, corresponding to the varia-
tion in clinical appearance, cutaneous or mucosal lesions
generally exhibit intracellular edema of the stratum
spinosumof the epithelium and edema of the superficial
connective tissue, which may actually produce subepider-
mal vesicles with varying degrees of inflammatory cell
infiltration (chiefly by lymphocytes, but often including
neutrophils and eosinophils) (14). Anaphylactic stomatitis
arises after the drug enters the circulatory system and
binds to IgE-mast cell complexes (15). Oral lesions may
occur alone or in association with urticarial skin lesions or
other signs and symptoms of anaphylaxis (such as
Int J Oral-Med Sci 11(1):57-61, 2012 59
Fig. 3. Follow-up 3 weeks after starting steroid treatment,showing complete healing of lesions on the vermilion border ofthe lip.
Fig. 4. Follow-up 3 weeks after starting steroid treatment,showing healed lesions on the dorsal surface of the tongue.
hoarseness, respiratory distress and vomiting). The affected
mucosa exhibits diffuse distribution of lesions, varying in
appearance from multiple areas of erythema to extensive
areas of erosion or ulceration. The histopathological features
of anaphylactic stomatitis typically reveal a non-specific
pattern of subacute mucositis that contains lymphocytes
intermixed with eosinophils and neutrophils (15). Such
reactions in the oral mucosa are considerably less common
than cutaneous reactions, and present in various patterns.
Common reactions produced in the oral cavity are
stomatitis, ulceration, gingival hyperplasia, pigmentation,
altered salivary function and altered taste sensation(15, 16).
However, some authors believe that separation of these
entities leads to unnecessary confusion and that terms like
stomatitis medicamentosa should be discarded (16). The
final diagnosis in this case was confirmed based on skin
testing, increased eosinophil counts and an increased IgE
level suggestive of anaphylactic reaction. Various tests can
help in diagnosing type I hypersensitivity reaction, such as
radioallergosorbent tests (RASTs) to detect the amount of
IgE antibody reacting with the suspected or known allergen
(17), leukocyte histamine release assays, surface markers
for basophil activation and leukotriene release tests(18).
Mechanism of ulcer healing
Ulcer healing is a complex process that involves cell
migration, proliferation, re-epithelialization, angiogenesis
and matrix deposition leading to scar formation (19). All
these processes are controlled by growth factors, transcrip-
tion factors and cytokines. Granulation tissue develops at the
ulcer base within 48-72 h after ulceration. Epithelial cells at
the ulcer margin undergo dedifferentiation, express epider-
mal growth factors and start to actively proliferate. These
cells migrate from the ulcer margin on to the granulation
tissue to re-epithelialize the ulcer base. Granulation tissue
consists of macrophages, fibroblasts and proliferating
endothelial cells that form microvessels throughout the
process of angiogenesis(20). The growth of these structures
is stimulated by cytokines, IL-1 and tumor necrosis factor α.
As the granulation tissue matures, it becomes more fibrous
through condensation of collagen bundles and the surface of
the lesion becomes epithealized and leads to scar formation.
Diagnostic Testing
Diagnosis of an allergic reaction is typically based on the
medical history, clinical findings and the results of patch
testing. Some practitioners use patch tests to confirm the
diagnosis of type IV allergic reaction. Limits exist to the
utility of patch tests, due to their poor sensitivity and
relatively high rate of false-negative results(21). The skin
test (prick test) helps in diagnosis of type I allergic reaction.
This test involves intradermal inoculation of suspected
antigens. The results are then read within 15-30 min. If the
result is positive, red, papular or vesicular reactions will be
apparent on the skin. These tests are used in the diagnosis of
drug and food allergies, which may manifest as ulcerative
lesions of the oral mucosa(22).
Management
The causative agent should be discontinued and, if
necessary, replaced with another drug that provides a
similar therapeutic result. Mild localized lesions can be
relieved by administration of topical cortisone or antihist-
amines, while secondary infection can be prevented by use
of germicidal drugs. Generalized and severe lesions warrant
the use of adrenaline or systemic steroids.
Conclusion
Almost all over- the- counter drugs are capable of causing
adverse reactions. The oral manifestations of pharmacother-
apy are often non-specific and vary in significance. These
undesirable effects can mimic many disease processes. To
avoid unnecessary diagnostic procedures and treatments,
clinicians need to recognize the disorder to allow quick and
accurate diagnosis.
References
1. Davis C, Squier CA, Lilly GE: Irritant contact stomatitis:
review of the condition. J Periodontal ,69: 620-631, 1998.
2. LeSuer BW, Yiannias AJ: Contact stomatitis. Dermatol Clin ,
21: 105-114, 2003.
3. Scott S, Rossi DE , Greenberg MS: Intraoral contact allergy. A
literature review and case reports. J Am Dent Assoc, 129:
1435-1441, 1998.
4. Matthews TG: Medication side effects of dental interest. J
Prosthet Dent , 64: 219-226, 1990.
5. Axell T: Hypersensitivity of the oral mucosa: clinics and
pathology. Acta Odontol Scand ,59: 315-319, 2001.
6. Greenberg PA: Immunotherapy update: mechanism of action.
Allergy Asthma Proc; 23: 373-376 2001.
7. Allison TJ, Winter CC, Fourrie JJ: Structure of a human
gamma delta T cell antigen receptor. Nature ,411: 820-824;
2001.
60 Int J Oral-Med Sci 11(1):57-61, 2012
8. Bischoff SC, Sellga G, Lorentz A, Reab R: IL-4 enhances
proliferation and mediator release in mature human mast
cells. Proc Nat Acad Sci U S A, 96: 8080-8085, 1999.
9. Gleich GJ, Adolphson CR: The eosinophilic leukocyte: struc-
ture and function. Adv Immunol, 39: 177-211, 1989.
10. Semenzato G, Bortoli M, Brunetta E: Agostinic. Immunology
and pathophysiology. Eur Respir Monograph ,10: 49-63, 2005.
11. Lankeranil L, Baron ED: Photosensitivity to exogenous
agents. J Cutan Med Surgn, 8: 424-431, 2004.
12. Roujeau JC, Kelly JP, Lugi Naldi MS, Rzany B, Stern R,
Anderson RN : Medication use and the risk of Stevens-
Johnson syndrome or toxic epidermal necrolysis. The New
England Journal of Medicine, 333: 1600-1608, 2005.
13. Kristina E, Archambault Ward R, Tracey L: Severe adverse
skin reactions to non steroidal anti inflammatory drugs: a
review of the literature. American Journal of Health-System
Pharmacy, 67: 206-213, 2010.
14. Rajendran R. Diseases of the skin. In: Rajendran R,
Sivapathasundaram B (eds.) Shaferʼs Textbook of Oral
Pathology, 6th ed. Elsevier, India: 2009. p 807.
15. SivapathaSundaram B: Allergic and immunological diseases of
the oral cavity. In: Rajendran R, Sivapathasundaram B (eds.)
Shaferʼs Textbook of Oral Pathology, 6th ed. Elsevier, India:
2009. p 673-674.
16. Greenberg MS: Ulcerative, vesicular and bullous lesions. In:
Lynch MA, Brightman VJ, Greenberg MS (eds.) Burketʼs
Oral Medicine. Diagnosis and Treatment. 9th ed. Lippincott,
Philadelphia: 2000. p 23.
17. Smith TF: Allergy testing in clinical practice. Ann Allergy, 68:
293-301, 1992
18. Primeau MN, Adkinson NF Jr: Recent advances in the
diagnosis of drug allergy. Curr Opin Allergy Clin Immunol, 1:
337-341, 2001.
19. Tarnawski A: Molecular mechanism of ulcer healing. Drug
News Perspect, 13: 158-168, 2000.
20. Risau W: Mechanisms of angiogenesis. Nature, 386: 671-673,
1997.
21. Forte G, Petrucci F, Bocca B: Metal allergens of growing
significance: epidemiology, immunotoxicology, strategies for
testing and prevention inflammation and allergy. Inflamm
Allergy Drug Targets, 7: 1-18, 2008.
22. Yamauchi R, Morita A, Tsuji T: Pacemaker dermatitis from
titanium. Contact Dermatitis ,42: 52-53, 2000.
Int J Oral-Med Sci 11(1):57-61, 2012 61